ペースメーカーの市場規模、シェア、動向分析レポート：製品別、用途別、最終用途別、地域別、セグメント別予測、2025年～2030年

ペースメーカー市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界のペースメーカー市場規模は2030年までに77億米ドルに達する見込みです。

同市場は2025～2030年にかけてCAGR 5.7%で成長すると予測されています。同市場は、医療技術の進歩や心臓リズム管理ソリューションに対する世界の需要の増加を背景に、着実な成長を遂げています。リードレスペースメーカー、デバイスの小型化、電池寿命の改善などの技術革新により、ペースメーカーの植え込みの有効性と利便性が大幅に向上しています。また、遠隔モニタリング機能を統合することで、医療プロバイダーがペースメーカーの機能や患者の健康状態を遠隔で追跡できるようになり、通院回数が減るなど、患者のケアも向上しています。2024年11月、ベルン大学病院において欧州初の単室式ワイヤレス心臓ペースメーカー植え込み手術が行われました。アラブ首長国連邦の専門家が主導したこの手術は、同国が医療技術革新のリーダーとしての地位を確立し、地域の医療専門家の育成に力を注いでいることを裏付けています。

同市場は、徐脈、不整脈、心不全などの心臓疾患の治療に一層注力することで利益を得ています。心血管系疾患が依然として世界の主要死因の1つであることから、信頼性が高く効果的なペーシングデバイスの必要性は高まり続けています。ペースメーカーは、患者の予後を改善するための重要なソリューションと見なされるようになってきており、病院や外来センターで広く採用されるようになってきています。ペースメーカー技術の絶え間ない進歩と心臓治療への需要の高まりにより、市場は今後数年間も力強い成長を維持すると予想されます。2023年11月、MedStar Washington Hospital Centerは、心拍数が異常に遅い患者向けにAveir DRリードレスペースメーカーシステムを提供する米国初の施設の1つとなりました。

ペースメーカー市場レポートハイライト

• 植え込み型ペースメーカーは、心臓リズム障害の治療に有効であることが証明され、臨床現場で広く採用されているため、2024年には市場シェアの68.0%を占め、製品カテゴリーを支配しました。
• 2024年、徐脈部門は、特に高齢者層における徐脈の高い有病率により、用途別で27.5%の大きなシェアを占めました。
• 最終用途では、先進的医療インフラと病院環境で利用可能な専門的ケアにより、病院セグメントが2024年に支配的でした。外来患者施設は、低侵襲手技の採用増加と回復時間の短縮により、CAGR最速で成長すると予測されています。
• 北米は、先進的な医療インフラ、高い医療費、革新的なペースメーカー技術の早期導入により、世界市場の43.4%で最大のシェアを占めています。
• アジア太平洋は、心血管疾患有病率の上昇、医療アクセスの改善、同地域における医療投資の増加により、予測期間中に最も速いCAGRで成長すると予測されています。
• 競合の特徴は、主要企業が製品の発売、販売契約、戦略的パートナーシップなどの戦略を実施し、市場シェアを大きく拡大していることです。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 ペースメーカー市場の変数、動向、範囲

• 市場系統の展望
  • 親市場の展望
  • 関連/付随市場の展望
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• ペースメーカー市場分析ツール
  • 産業分析-ポーターのファイブフォース分析
  • PESTEL分析

第4章 ペースメーカー市場：製品別、推定・動向分析

• 世界のペースメーカー市場：製品ダッシュボード
• 世界のペースメーカー市場：製品変動分析
• 世界のペースメーカー市場規模と予測と動向分析、2018～2030年
• 体外ペースメーカー
  • シングルチャンバー
  • デュアルチャンバー
• 埋め込み型ペースメーカー
  • 従来型
  • リードレス

第5章 ペースメーカー市場：用途別、推定・動向分析

• 世界のペースメーカー市場：用途ダッシュボード
• 世界のペースメーカー市場：用途変動分析
• 世界のペースメーカー市場規模と予測と動向分析、2018～2030年
• 徐脈
• 急性心筋梗塞
• 不整脈
  • 心房細動
  • ハートブロック
  • QT延長症候群
• うっ血性心不全
• その他

第6章 ペースメーカー市場：最終用途別、推定・動向分析

• 世界のペースメーカー市場：最終用途ダッシュボード
• 世界のペースメーカー市場：最終用途変動分析
• 世界のペースメーカー市場規模と予測と動向分析、2018～2030年
• 病院
• 外来施設

第7章 ペースメーカー市場：国、製品、用途、最終用途による地域別、推定・動向分析

• 地域ダッシュボード
• 市場規模と予測動向分析、2018～2030年
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • ノルウェー
  • スウェーデン
  • デンマーク
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 主要メーカーによる最近の動向と影響分析
• 企業/競合の分類
• 主要企業の市場シェア分析、2024年
• 企業プロファイル
  • Osypka Medical GmbH
  • Zoll Medical Corporation
  • Medtronic
  • BIOTRONIK
  • MicroPort Scientific Corporation
  • MEDICO SpA
  • Pacetronix
  • Oscor Inc
  • Boston Scientific Corporation
  • Lepu Medical Technology（Beijing）Co., Ltd.

List of Tables

• Table 1 List of Abbreviations
• Table 2 Global Pacemaker Market, by product, 2018 - 2030 (USD Million)
• Table 3 Global Pacemaker Market, by application, 2018 - 2030 (USD Million)
• Table 4 Global Pacemaker Market, by end use, 2018 - 2030 (USD Million)
• Table 5 Global Pacemaker Market, by region, 2018 - 2030 (USD Million)
• Table 6 North America Pacemaker Market, by country, 2018 - 2030 (USD Million)
• Table 7 North America Pacemaker Market, by product, 2018 - 2030 (USD Million)
• Table 8 North America Pacemaker Market, by application, 2018 - 2030 (USD Million)
• Table 9 North America Pacemaker Market, by end use, 2018 - 2030 (USD Million)
• Table 10 U.S. Pacemaker Market, by product, 2018 - 2030 (USD Million)
• Table 11 U.S. Pacemaker Market, by application, 2018 - 2030 (USD Million)
• Table 12 U.S. Pacemaker Market, by end use, 2018 - 2030 (USD Million)
• Table 13 Canada Pacemaker Market, by product, 2018 - 2030 (USD Million)
• Table 14 Canada Pacemaker Market, by application, 2018 - 2030 (USD Million)
• Table 15 Canada Pacemaker Market, by end use, 2018 - 2030 (USD Million)
• Table 16 Mexico Pacemaker Market, by product, 2018 - 2030 (USD Million)
• Table 17 Mexico Pacemaker Market, by application, 2018 - 2030 (USD Million)
• Table 18 Mexico Pacemaker Market, by end use, 2018 - 2030 (USD Million)
• Table 19 Europe Pacemaker Market, by country, 2018 - 2030 (USD Million)
• Table 20 Europe Pacemaker Market, by product, 2018 - 2030 (USD Million)
• Table 21 Europe Pacemaker Market, by application, 2018 - 2030 (USD Million)
• Table 22 Europe Pacemaker Market, by end use, 2018 - 2030 (USD Million)
• Table 23 Germany Pacemaker Market, by product, 2018 - 2030 (USD Million)
• Table 24 Germany Pacemaker Market, by application, 2018 - 2030 (USD Million)
• Table 25 Germany Pacemaker Market, by end use, 2018 - 2030 (USD Million)
• Table 26 UK Pacemaker Market, by product, 2018 - 2030 (USD Million)
• Table 27 UK Pacemaker Market, by application, 2018 - 2030 (USD Million)
• Table 28 UK Pacemaker Market, by end use, 2018 - 2030 (USD Million)
• Table 29 France Pacemaker Market, by product, 2018 - 2030 (USD Million)
• Table 30 France Pacemaker Market, by application, 2018 - 2030 (USD Million)
• Table 31 France Pacemaker Market, by end use, 2018 - 2030 (USD Million)
• Table 32 Italy Pacemaker Market, by product, 2018 - 2030 (USD Million)
• Table 33 Italy Pacemaker Market, by application, 2018 - 2030 (USD Million)
• Table 34 Italy Pacemaker Market, by end use, 2018 - 2030 (USD Million)
• Table 35 Spain Pacemaker Market, by product, 2018 - 2030 (USD Million)
• Table 36 Spain Pacemaker Market, by application, 2018 - 2030 (USD Million)
• Table 37 Spain Pacemaker Market, by end use, 2018 - 2030 (USD Million)
• Table 38 Denmark Pacemaker Market, by product, 2018 - 2030 (USD Million)
• Table 39 Denmark Pacemaker Market, by application, 2018 - 2030 (USD Million)
• Table 40 Denmark Pacemaker Market, by end use, 2018 - 2030 (USD Million)
• Table 41 Sweden Pacemaker Market, by product, 2018 - 2030 (USD Million)
• Table 42 Sweden Pacemaker Market, by application, 2018 - 2030 (USD Million)
• Table 43 Sweden Pacemaker Market, by end use, 2018 - 2030 (USD Million)
• Table 44 Norway Pacemaker Market, by product, 2018 - 2030 (USD Million)
• Table 45 Norway Pacemaker Market, by application, 2018 - 2030 (USD Million)
• Table 46 Norway Pacemaker Market, by end use, 2018 - 2030 (USD Million)
• Table 47 Asia Pacific Pacemaker Market, by country, 2018 - 2030 (USD Million)
• Table 48 Asia Pacific Pacemaker Market, by product, 2018 - 2030 (USD Million)
• Table 49 Asia Pacific Pacemaker Market, by application, 2018 - 2030 (USD Million)
• Table 50 Asia Pacific Pacemaker Market, by end use, 2018 - 2030 (USD Million)
• Table 51 China Pacemaker Market, by product, 2018 - 2030 (USD Million)
• Table 52 China Pacemaker Market, by application, 2018 - 2030 (USD Million)
• Table 53 China Pacemaker Market, by end use, 2018 - 2030 (USD Million)
• Table 54 Japan Pacemaker Market, by product, 2018 - 2030 (USD Million)
• Table 55 Japan Pacemaker Market, by application, 2018 - 2030 (USD Million)
• Table 56 Japan Pacemaker Market, by end use, 2018 - 2030 (USD Million)
• Table 57 India Pacemaker Market, by product, 2018 - 2030 (USD Million)
• Table 58 India Pacemaker Market, by application, 2018 - 2030 (USD Million)
• Table 59 India Pacemaker Market, by end use, 2018 - 2030 (USD Million)
• Table 60 South Korea Pacemaker Market, by product, 2018 - 2030 (USD Million)
• Table 61 South Korea Pacemaker Market, by application, 2018 - 2030 (USD Million)
• Table 62 South Korea Pacemaker Market, by end use, 2018 - 2030 (USD Million)
• Table 63 Australia Pacemaker Market, by product, 2018 - 2030 (USD Million)
• Table 64 Australia Pacemaker Market, by application, 2018 - 2030 (USD Million)
• Table 65 Australia Pacemaker Market, by end use, 2018 - 2030 (USD Million)
• Table 66 Thailand Pacemaker Market, by product, 2018 - 2030 (USD Million)
• Table 67 Thailand Pacemaker Market, by application, 2018 - 2030 (USD Million)
• Table 68 Thailand Pacemaker Market, by end use, 2018 - 2030 (USD Million)
• Table 69 Latin America Pacemaker Market, by country, 2018 - 2030 (USD Million)
• Table 70 Latin America Pacemaker Market, by product, 2018 - 2030 (USD Million)
• Table 71 Latin America Pacemaker Market, by application, 2018 - 2030 (USD Million)
• Table 72 Latin America Pacemaker Market, by end use, 2018 - 2030 (USD Million)
• Table 73 Brazil Pacemaker Market, by product, 2018 - 2030 (USD Million)
• Table 74 Brazil Pacemaker Market, by application, 2018 - 2030 (USD Million)
• Table 75 Brazil Pacemaker Market, by end use, 2018 - 2030 (USD Million)
• Table 76 Argentina Pacemaker Market, by product, 2018 - 2030 (USD Million)
• Table 77 Argentina Pacemaker Market, by application, 2018 - 2030 (USD Million)
• Table 78 Argentina Pacemaker Market, by end use, 2018 - 2030 (USD Million)
• Table 79 Middle East & Africa Pacemaker Market, by product, 2018 - 2030 (USD Million)
• Table 80 Middle East & Africa Pacemaker Market, by application, 2018 - 2030 (USD Million)
• Table 81 Middle East & Africa Pacemaker Market, by end use, 2018 - 2030 (USD Million)
• Table 82 South Africa Pacemaker Market, by product, 2018 - 2030 (USD Million)
• Table 83 South Africa Pacemaker Market, by application, 2018 - 2030 (USD Million)
• Table 84 South Africa Pacemaker Market, by end use, 2018 - 2030 (USD Million)
• Table 85 Saudi Arabia Pacemaker Market, by product, 2018 - 2030 (USD Million)
• Table 86 Saudi Arabia Pacemaker Market, by application, 2018 - 2030 (USD Million)
• Table 87 Saudi Arabia Pacemaker Market, by end use, 2018 - 2030 (USD Million)
• Table 88 UAE Pacemaker Market, by product, 2018 - 2030 (USD Million)
• Table 89 UAE Pacemaker Market, by application, 2018 - 2030 (USD Million)
• Table 90 UAE Pacemaker Market, by end use, 2018 - 2030 (USD Million)
• Table 91 Kuwait Pacemaker Market, by product, 2018 - 2030 (USD Million)
• Table 92 Kuwait Pacemaker Market, by application, 2018 - 2030 (USD Million)
• Table 93 Kuwait Pacemaker Market, by end use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Information procurement
• Fig. 3 Primary research pattern
• Fig. 4 Market research approaches
• Fig. 5 Value chain-based sizing & forecasting
• Fig. 6 Market formulation & validation
• Fig. 7 Pacemaker Market segmentation
• Fig. 8 Market snapshot, 2024
• Fig. 9 Market trends & outlook
• Fig. 10 Market driver relevance analysis (current & future impact)
• Fig. 11 Market restraint relevance analysis (current & future impact)
• Fig. 12 SWOT analysis, by factor (political & legal, economic and technological)
• Fig. 13 Porter's five forces analysis
• Fig. 14 Global Pacemaker Market: Product Outlook Key Takeaways
• Fig. 15 Global Pacemaker Market: Product Movement Analysis
• Fig. 16 Global External Pacemakers Market, 2018 - 2030 (USD Million)
• Fig. 17 Global External Pacemakers Single Chamber Market, 2018 - 2030 (USD Million)
• Fig. 18 Global External Pacemakers Dual Chamber Market, 2018 - 2030 (USD Million)
• Fig. 19 Global Implantable Pacemaker Market, 2018 - 2030 (USD Million)
• Fig. 20 Global Implantable Pacemaker Conventional Market, 2018 - 2030 (USD Million)
• Fig. 21 Global Implantable Pacemaker Conventional Single Chamber Market, 2018 - 2030 (USD Million)
• Fig. 22 Global Implantable Pacemaker Conventional Dual Chamber Market, 2018 - 2030 (USD Million)
• Fig. 23 Global Implantable Pacemaker Conventional Biventricular Chamber Market, 2018 - 2030 (USD Million)
• Fig. 24 Global Implantable Pacemaker Leadless Market, 2018 - 2030 (USD Million)
• Fig. 25 Global Implantable Pacemaker Leadless Single Chamber Market, 2018 - 2030 (USD Million)
• Fig. 26 Global Implantable Pacemaker Leadless Dual Chamber Market, 2018 - 2030 (USD Million)
• Fig. 27 Global Pacemaker Market: Application Outlook Key Takeaways
• Fig. 28 Global Pacemaker Market: Application Movement Analysis
• Fig. 29 Global Bradycardia Market, 2018 - 2030 (USD Million)
• Fig. 30 Global Acute Myocardial Infarction Market, 2018 - 2030 (USD Million)
• Fig. 31 Global Arrhythmias Market, 2018 - 2030 (USD Million)
• Fig. 32 Global Atrial Fibrillation Market, 2018 - 2030 (USD Million)
• Fig. 33 Global Heart Block Market, 2018 - 2030 (USD Million)
• Fig. 34 Global Long QT Syndrome Market, 2018 - 2030 (USD Million)
• Fig. 35 Global Congestive Heart Failure Market, 2018 - 2030 (USD Million)
• Fig. 36 Global Others Market, 2018 - 2030 (USD Million)
• Fig. 37 Global Pacemaker Market: End Use Outlook Key Takeaways
• Fig. 38 Global Pacemaker Market: End Use Movement Analysis
• Fig. 39 Global Hospitals Market, 2018 - 2030 (USD Million)
• Fig. 40 Global Outpatient Facilities Market, 2018 - 2030 (USD Million)
• Fig. 41 Regional Marketplace: Key Takeaways
• Fig. 42 Regional outlook, 2024 & 2030
• Fig. 43 Global Pacemaker Market: Region Movement Analysis
• Fig. 44 North America Pacemaker Market, 2018 - 2030 (USD Million)
• Fig. 45 U.S. Pacemaker Market, 2018 - 2030 (USD Million)
• Fig. 46 Canada Pacemaker Market, 2018 - 2030 (USD Million)
• Fig. 47 Mexico Pacemaker Market, 2018 - 2030 (USD Million)
• Fig. 48 Europe Pacemaker Market, 2018 - 2030 (USD Million)
• Fig. 49 Germany Pacemaker Market, 2018 - 2030 (USD Million)
• Fig. 50 UK Pacemaker Market, 2018 - 2030 (USD Million)
• Fig. 51 France Pacemaker Market, 2018 - 2030 (USD Million)
• Fig. 52 Italy Pacemaker Market, 2018 - 2030 (USD Million)
• Fig. 53 Spain Pacemaker Market, 2018 - 2030 (USD Million)
• Fig. 54 Spain Pacemaker Market, 2018 - 2030 (USD Million)
• Fig. 55 Denmark Pacemaker Market, 2018 - 2030 (USD Million)
• Fig. 56 Sweden Pacemaker Market, 2018 - 2030 (USD Million)
• Fig. 57 Norway Pacemaker Market, 2018 - 2030 (USD Million)
• Fig. 58 Asia pacific Pacemaker Market, 2018 - 2030 (USD Million)
• Fig. 59 Japan Pacemaker Market, 2018 - 2030 (USD Million)
• Fig. 60 China Pacemaker Market, 2018 - 2030 (USD Million)
• Fig. 61 India Pacemaker Market, 2018 - 2030 (USD Million)
• Fig. 62 Australia Pacemaker Market, 2018 - 2030 (USD Million)
• Fig. 63 South Korea Pacemaker Market, 2018 - 2030 (USD Million)
• Fig. 64 Thailand Pacemaker Market, 2018 - 2030 (USD Million)
• Fig. 65 Latin America Pacemaker Market, 2018 - 2030 (USD Million)
• Fig. 66 Brazil Pacemaker Market, 2018 - 2030 (USD Million)
• Fig. 67 Argentina Pacemaker Market, 2018 - 2030 (USD Million)
• Fig. 68 Middle East and Africa Pacemaker Market, 2018 - 2030 (USD Million)
• Fig. 69 South Africa Pacemaker Market, 2018 - 2030 (USD Million)
• Fig. 70 Saudi Arabia Pacemaker Market, 2018 - 2030 (USD Million)
• Fig. 71 UAE Pacemaker Market, 2018 - 2030 (USD Million)
• Fig. 72 Kuwait Pacemaker Market, 2018 - 2030 (USD Million)
• Fig. 73 Strategy framework

Pacemaker Market Growth & Trends:

The global pacemaker market size is expected to reach USD 7.7 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 5.7% from 2025 to 2030. The market is experiencing steady growth, driven by advancements in medical technology and an increasing global demand for heart rhythm management solutions. Technological innovations, such as leadless pacemakers, smaller devices, and improved battery life, have significantly enhanced the effectiveness and convenience of pacemaker implantation. Integrating remote monitoring capabilities has also improved patient care by allowing healthcare providers to track pacemaker function and patient health remotely, reducing hospital visits. In November 2024, Europe witnessed its first single-chamber, wireless cardiac pacemaker implantation at Bern University Hospital. This procedure, led by experts from the UAE, underscores the country's position as a leader in medical innovation and its commitment to training regional healthcare professionals.

The market benefits from a greater focus on treating heart conditions such as bradycardia, arrhythmias, and heart failure. As cardiovascular diseases remain one of the leading causes of death globally, the need for reliable and effective pacing devices continues to rise. Pacemakers are increasingly seen as a critical solution for improving patient outcomes, leading to their widespread adoption in hospitals and outpatient centers. With continuous advancements in pacemaker technology and a growing demand for cardiac care, the market is expected to maintain strong growth in the coming years. In November 2023, MedStar Washington Hospital Center became one of the first institutions in the U.S. to offer the Aveir DR Leadless Pacemaker System for patients with abnormally slow heart rates.

Pacemaker Market Report Highlights:

• The implantable pacemaker segment dominated the product category in 2024 with 68.0% of the market share due to its proven effectiveness in treating heart rhythm disorders and widespread adoption in clinical practice.
• In 2024, the bradycardia segment accounted for a substantial share of 27.5% by application owing to the high prevalence of bradycardia, particularly among aging populations.
• In terms of end use, the hospital segment dominated in 2024 due to the advanced healthcare infrastructure and specialized care available in hospital settings. Outpatient facilities are anticipated to grow at the fastest CAGR owing to the increasing adoption of minimally invasive procedures and shorter recovery times.
• North America held the largest share of 43.4% of the global market due to advanced healthcare infrastructure, high healthcare spending, and early adoption of innovative pacemaker technologies.
• Asia Pacific is anticipated to grow at the fastest CAGR over the forecast period due to rising cardiovascular disease prevalence, improving healthcare access, and increasing healthcare investments in the region.
• The competition features key players implementing strategies like product launches, distribution agreements, and strategic partnerships, which have greatly expanded their market share.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Application
  • 1.2.3. End Use
  • 1.2.4. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Volume price analysis (Model 2)
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Application outlook
  • 2.2.3. End use outlook
• 2.3. Competitive Insights

Chapter 3. Pacemaker Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Rising prevalence of cardiovascular diseases (CVD)
    • 3.2.1.2. Favorable reimbursement policies
    • 3.2.1.3. Technological advancements
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Stringent regulation and approvals
    • 3.2.2.2. Product Recalls
• 3.3. Pacemaker Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. Pacemaker Market: Product Estimates & Trend Analysis

• 4.1. Global Pacemaker Market: Product Dashboard
• 4.2. Global Pacemaker Market: Product Movement Analysis
• 4.3. Global Pacemaker Market Size & Forecasts and Trend Analysis, 2018 to 2030
• 4.4. External Pacemakers
  • 4.4.1. External pacemakers market estimates and forecasts 2018 to 2030 (USD Billion)
  • 4.4.2. Single Chamber
    • 4.4.2.1. Single Chamber market estimates and forecasts 2018 to 2030 (USD Billion)
  • 4.4.3. Dual Chamber
    • 4.4.3.1. Dual Chamber market estimates and forecasts 2018 to 2030 (USD Billion)
• 4.5. Implantable Pacemakers
  • 4.5.1. Implantable pacemakers market estimates and forecasts 2018 to 2030 (USD Billion)
  • 4.5.2. Conventional
    • 4.5.2.1. Conventional market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.5.2.2. Single Chamber
      • 4.5.2.2.1. Single Chamber market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.5.2.3. Dual Chamber
      • 4.5.2.3.1. Dual Chamber market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.5.2.4. Biventricular Chamber
      • 4.5.2.4.1. Biventricular Chamber market estimates and forecasts 2018 to 2030 (USD Billion)
  • 4.5.3. Leadless
    • 4.5.3.1. Leadless market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.5.3.2. Single Chamber
      • 4.5.3.2.1. Single Chamber market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.5.3.3. Dual Chamber
      • 4.5.3.3.1. Dual Chamber market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 5. Pacemaker Market: Application Estimates & Trend Analysis

• 5.1. Global Pacemaker Market: Application Dashboard
• 5.2. Global Pacemaker Market: Application Movement Analysis
• 5.3. Global Pacemaker Market Size & Forecasts and Trend Analysis, 2018 to 2030
• 5.4. Bradycardia
  • 5.4.1. Bradycardia market estimates and forecasts 2018 to 2030 (USD Billion)
• 5.5. Acute Myocardial Infarction
  • 5.5.1. Acute myocardial infarction market estimates and forecasts 2018 to 2030 (USD Billion)
• 5.6. Arrhythmias
  • 5.6.1. Arrhythmias market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.6.2. Atrial Fibrillation
    • 5.6.2.1. Atrial Fibrillation market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.6.3. Heart Block
    • 5.6.3.1. Heart Block market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.6.4. Long QT Syndrome
    • 5.6.4.1. Long QT syndrome market estimates and forecasts 2018 to 2030 (USD Billion)
• 5.7. Congestive Heart Failure
  • 5.7.1. Congestive heart failure market estimates and forecasts 2018 to 2030 (USD Billion)
• 5.8. Others
  • 5.8.1. Others market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 6. Pacemaker Market: End Use Estimates & Trend Analysis

• 6.1. Global Pacemaker Market: End Use Dashboard
• 6.2. Global Pacemaker Market: End Use Movement Analysis
• 6.3. Global Pacemaker Market Size & Forecasts and Trend Analysis, 2018 to 2030
• 6.4. Hospitals
  • 6.4.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Billion)
• 6.5. Outpatient Facilities
  • 6.5.1. Outpatient Facilities market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 7. Cardiovascular Devices Market: Regional Estimates & Trend Analysis by Country, Product, Application, and End-use

• 7.1. Regional Dashboard
• 7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030
• 7.3. North America
  • 7.3.1. U.S.
    • 7.3.1.1. Key country dynamics
    • 7.3.1.2. Regulatory framework/ reimbursement structure
    • 7.3.1.3. Competitive scenario
    • 7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.3.2. Canada
    • 7.3.2.1. Key country dynamics
    • 7.3.2.2. Regulatory framework/ reimbursement structure
    • 7.3.2.3. Competitive scenario
    • 7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.3.3. Mexico
    • 7.3.3.1. Key country dynamics
    • 7.3.3.2. Regulatory framework/ reimbursement structure
    • 7.3.3.3. Competitive scenario
    • 7.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
• 7.4. Europe
  • 7.4.1. UK
    • 7.4.1.1. Key country dynamics
    • 7.4.1.2. Regulatory framework/ reimbursement structure
    • 7.4.1.3. Competitive scenario
    • 7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.2. Germany
    • 7.4.2.1. Key country dynamics
    • 7.4.2.2. Regulatory framework/ reimbursement structure
    • 7.4.2.3. Competitive scenario
    • 7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.3. France
    • 7.4.3.1. Key country dynamics
    • 7.4.3.2. Regulatory framework/ reimbursement structure
    • 7.4.3.3. Competitive scenario
    • 7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.4. Italy
    • 7.4.4.1. Key country dynamics
    • 7.4.4.2. Regulatory framework/ reimbursement structure
    • 7.4.4.3. Competitive scenario
    • 7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.5. Spain
    • 7.4.5.1. Key country dynamics
    • 7.4.5.2. Regulatory framework/ reimbursement structure
    • 7.4.5.3. Competitive scenario
    • 7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.6. Norway
    • 7.4.6.1. Key country dynamics
    • 7.4.6.2. Regulatory framework/ reimbursement structure
    • 7.4.6.3. Competitive scenario
    • 7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.7. Sweden
    • 7.4.7.1. Key country dynamics
    • 7.4.7.2. Regulatory framework/ reimbursement structure
    • 7.4.7.3. Competitive scenario
    • 7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.8. Denmark
    • 7.4.8.1. Key country dynamics
    • 7.4.8.2. Regulatory framework/ reimbursement structure
    • 7.4.8.3. Competitive scenario
    • 7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Japan
    • 7.5.1.1. Key country dynamics
    • 7.5.1.2. Regulatory framework/ reimbursement structure
    • 7.5.1.3. Competitive scenario
    • 7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.2. China
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Regulatory framework/ reimbursement structure
    • 7.5.2.3. Competitive scenario
    • 7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.3. India
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Regulatory framework/ reimbursement structure
    • 7.5.3.3. Competitive scenario
    • 7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.4. Australia
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Regulatory framework/ reimbursement structure
    • 7.5.4.3. Competitive scenario
    • 7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.5. South Korea
    • 7.5.5.1. Key country dynamics
    • 7.5.5.2. Regulatory framework/ reimbursement structure
    • 7.5.5.3. Competitive scenario
    • 7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.6. Thailand
    • 7.5.6.1. Key country dynamics
    • 7.5.6.2. Regulatory framework/ reimbursement structure
    • 7.5.6.3. Competitive scenario
    • 7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. Latin America
  • 7.6.1. Brazil
    • 7.6.1.1. Key country dynamics
    • 7.6.1.2. Regulatory framework/ reimbursement structure
    • 7.6.1.3. Competitive scenario
    • 7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.2. Argentina
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Regulatory framework/ reimbursement structure
    • 7.6.2.3. Competitive scenario
    • 7.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 7.7. MEA
  • 7.7.1. South Africa
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Regulatory framework/ reimbursement structure
    • 7.7.1.3. Competitive scenario
    • 7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.2. Saudi Arabia
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Regulatory framework/ reimbursement structure
    • 7.7.2.3. Competitive scenario
    • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.3. UAE
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Regulatory framework/ reimbursement structure
    • 7.7.3.3. Competitive scenario
    • 7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.4. Kuwait
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Regulatory framework/ reimbursement structure
    • 7.7.4.3. Competitive scenario
    • 7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Manufacturers
• 8.2. Company/Competition Categorization
• 8.3. Key company market share analysis, 2024
• 8.4. Company Profiles
  • 8.4.1. Osypka Medical GmbH
    • 8.4.1.1. Company overview
    • 8.4.1.2. Financial performance
    • 8.4.1.3. Product benchmarking
    • 8.4.1.4. Strategic initiatives
  • 8.4.2. Zoll Medical Corporation
    • 8.4.2.1. Company overview
    • 8.4.2.2. Financial performance
    • 8.4.2.3. Product benchmarking
    • 8.4.2.4. Strategic initiatives
  • 8.4.3. Medtronic
    • 8.4.3.1. Company overview
    • 8.4.3.2. Financial performance
    • 8.4.3.3. Product benchmarking
    • 8.4.3.4. Strategic initiatives
  • 8.4.4. BIOTRONIK
    • 8.4.4.1. Company overview
    • 8.4.4.2. Financial performance
    • 8.4.4.3. Product benchmarking
    • 8.4.4.4. Strategic initiatives
  • 8.4.5. MicroPort Scientific Corporation
    • 8.4.5.1. Company overview
    • 8.4.5.2. Financial performance
    • 8.4.5.3. Product benchmarking
    • 8.4.5.4. Strategic initiatives
  • 8.4.6. MEDICO SpA
    • 8.4.6.1. Company overview
    • 8.4.6.2. Financial performance
    • 8.4.6.3. Product benchmarking
    • 8.4.6.4. Strategic initiatives
  • 8.4.7. Pacetronix
    • 8.4.7.1. Company overview
    • 8.4.7.2. Financial performance
    • 8.4.7.3. Product benchmarking
    • 8.4.7.4. Strategic initiatives
  • 8.4.8. Oscor Inc
    • 8.4.8.1. Company overview
    • 8.4.8.2. Financial performance
    • 8.4.8.3. Product benchmarking
    • 8.4.8.4. Strategic initiatives
  • 8.4.9. Boston Scientific Corporation
    • 8.4.9.1. Company overview
    • 8.4.9.2. Financial performance
    • 8.4.9.3. Product benchmarking
    • 8.4.9.4. Strategic initiatives
  • 8.4.10. Lepu Medical Technology (Beijing) Co., Ltd.
    • 8.4.10.1. Company overview
    • 8.4.10.2. Financial performance
    • 8.4.10.3. Product benchmarking
    • 8.4.10.4. Strategic initiatives